|
End-of-day quote
Shanghai S.E.
2026-09-22
|
5-day change | 1st Jan Change | ||
| 8.250 CNY | -0.84% |
|
-0.36% | -34.32% |
| 08-21 | KPC Pharmaceuticals,Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 07-27 | KPC Pharmaceuticals to Divest Stake in Nanjing Leads Biolabs | MT |
| Market Cap | 6.25B 932M 815M 766M 699M 1.31B 89.1B 1.31B 9.19B 3.55B 45.5B 3.5B 3.42B 147B | P/E 2026 * |
38.7x | P/E 2027 * | 18.5x |
|---|---|---|---|---|---|
| Enterprise Value | 6.25B 932M 815M 766M 699M 1.31B 89.1B 1.31B 9.19B 3.55B 45.5B 3.5B 3.42B 147B | EV / Sales 2026 * |
1.1x | EV / Sales 2027 * | 1x |
| Free-Float |
59.61% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -0.84% | ||
| 1 week | -0.36% | ||
| Current month | -3.73% | ||
| 1 month | -3.40% | ||
| 3 months | +1.98% | ||
| 6 months | -29.55% | ||
| Current year | -34.32% |
| 1 week | 8.05 |  | 8.38 |
| 1 month | 8.05 | | 8.77 |
| Current year | 7.45 | | 13.55 |
| 1 year | 7.45 | | 14.46 |
| 3 years | 7.45 | | 24.11 |
| 5 years | 7.45 | | 26.09 |
| 10 years | 5.95 | | 26.09 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zhi Qiang Sun
DFI | Director of Finance/CFO | - | 2023-01-02 |
Jiang Zhong
PSD | President | 51 | 2026-01-04 |
Yu Dong
IRC | Investor Relations Contact | 37 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Li Meng
BRD | Director/Board Member | - | - |
Jin Guo Xin
BRD | Director/Board Member | 64 | 2009-10-31 |
Hui Zhou
BRD | Director/Board Member | 55 | 2023-10-17 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.84% | -0.36% | -41.53% | -50.78% | 940M | |
| +0.45% | +3.00% | +55.00% | +112.54% | 1,038B | |
| -0.10% | +0.74% | +54.52% | +67.72% | 649B | |
| +0.28% | +0.82% | +19.15% | +73.63% | 467B | |
| -0.19% | +0.97% | +34.30% | +45.99% | 355B | |
| +0.28% | +2.30% | +18.47% | +26.67% | 269B | |
| +0.89% | +4.59% | +10.19% | +14.72% | 260B | |
| +4.34% | +9.21% | +43.44% | +53.25% | 213B | |
| -0.46% | -6.20% | -32.46% | -59.65% | 176B | |
| +1.40% | +4.35% | +35.72% | +103.53% | 187B | |
| Average | +0.57% | +1.12% | +19.68% | +38.76% | 361.61B | |
| Weighted average by Cap. | +0.47% | +1.55% | +36.34% | +67.11% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.66B 845M 738M 694M 633M 1.19B 80.75B 1.19B 8.33B 3.21B 41.24B 3.17B 3.1B 133B | 6.27B 936M 818M 769M 702M 1.32B 89.52B 1.32B 9.23B 3.56B 45.71B 3.52B 3.44B 147B |
| Net income | 164M 24.42M 21.34M 20.06M 18.3M 34.35M 2.33B 34.36M 241M 92.88M 1.19B 91.7M 89.69M 3.84B | 336M 50.12M 43.8M 41.16M 37.57M 70.5M 4.79B 70.52M 494M 191M 2.45B 188M 184M 7.89B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-22 | CN¥8.250 | -0.84% | 3,467,193 |
| 26-09-21 | CN¥8.320 | +2.21% | 5,121,462 |
| 26-09-18 | CN¥8.140 | +0.37% | 2,920,080 |
| 26-09-17 | CN¥8.110 | +0.12% | 2,906,600 |
| 26-09-16 | CN¥8.100 | -0.86% | 3,167,900 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600422 Stock
Select your edition
All financial news and data tailored to specific country editions
